A six-gene panel that predicts survival in men with castration-resistant prostate cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4539 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4539-4539

Author(s):

S. K. Subudhi ◽

G. Heller ◽

A. Anand ◽

D. C. Danila ◽

M. Fleisher ◽

...

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer

The Prostate ◽

10.1002/pros.23202 ◽

2016 ◽

Vol 76 (13) ◽

pp. 1160-1168 ◽

Author(s):

Matthias M. Heck ◽

Mark Thalgott ◽

Sebastian C. Schmid ◽

William K. Oh ◽

Yixuan Gong ◽

...

Keyword(s):

Prostate Cancer ◽

Whole Blood ◽

Castration Resistant Prostate Cancer ◽

Treatment Benefit ◽

Castration Resistant

Download Full-text

1072 A 2-gene panel derived from prostate cancer-enhanced transcripts in whole blood is prognostic for survival and predicts treatment benefit in metastatic castration-resistant prostate cancer

European Urology Supplements ◽

10.1016/s1569-9056(16)61073-4 ◽

2016 ◽

Vol 15 (3) ◽

pp. e1072

Author(s):

M. Heck ◽

M. Thalgott ◽

S. Schmid ◽

W. Oh ◽

Y. Gong ◽

...

Keyword(s):

Prostate Cancer ◽

Whole Blood ◽

Castration Resistant Prostate Cancer ◽

Treatment Benefit ◽

Castration Resistant

Download Full-text

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer

10.1055/s-0040-1708342 ◽

2020 ◽

Author(s):

T Derlin ◽

R Werner ◽

C Henkenberens ◽

TL Ross ◽

FM Bengel

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant

Download Full-text

Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T

Endocrine Abstracts ◽

10.1530/endoabs.47.oc32 ◽

2016 ◽

Author(s):

Harshad R. Kulkarni ◽

Aviral Singh ◽

Christiane Schuchardt ◽

Karin Niepsch ◽

Richard P. Baum

Keyword(s):

Prostate Cancer ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant ◽

Specific Membrane

Download Full-text

New combination therapies for castration-resistant prostate cancer

Oncology Abstracts ◽

10.1530/oncolabs.1.p031 ◽

2019 ◽

Author(s):

Mitchell G Lawrence ◽

Laura H Porter ◽

Daisuke Obinata ◽

Shahneen Sandhu ◽

Luke A Selth ◽

...

Keyword(s):

Prostate Cancer ◽

New Combination ◽

Combination Therapies ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

The role of microbiota in driving castration-resistant prostate cancer

10.26226/morressier.5f69edb69b74b699bf38c5cf ◽

2020 ◽

Author(s):

Arianna Calcinotto

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

Case Medical Research ◽

10.31525/cmr-1904aca ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Case Medical Research ◽

10.31525/ct1-nct03851640 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Case Medical Research ◽

10.31525/ct1-nct03874884 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer

Case Medical Research ◽

10.31525/ct1-nct03972657 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text